Moderna and Merck announced plans to file an application for United States Food and Drug Administration approval for their personalized cancer vaccine before the end of 2026

Bb5a31f81Topic

Health

Biological preparations that stimulate the immune system to recognize and protect against infectious diseases by inducing a targeted immune response.

1 debate·6,997 claims·43 news stories

0